Abdominal pain and nausea in a woman having an acute porphyria attack was initially misdiagnosed as a natural response…
Marisa Wexler, MS
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Wexler, MS
Applications are now open for Find Your Shadow 2021, an adventure program from Shadow Jumpers that aims to help…
Note: This story was updated on Feb. 2, 2021, to note that cutaneous symptoms are more common in VP and…
A combined liver and kidney transplant can be an effective treatment for acute intermittent porphyria (AIP) patients with kidney…
An Argentinian man with two different porphyria-causing mutations was described in a new case report. The unusual findings highlight…
The National Organization for Rare Disorders (NORD)’s RareLaunch training program will host two days of free virtual workshops…
Voting is underway for the 2021 Pet Calendar Contest organized by the American Porphyria Foundation (APF). Through Oct.
A majority of rare disease patients using telehealth during the COVID-19 pandemic thought the experience positive, and many would like…
Vision loss in both eyes can be a sign of acute porphyria in children when associated with unexplained abdominal…
Alnylam Pharmaceuticals is not expecting the production and supply of Givlaari (givosiran), a treatment for acute hepatic…